Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014951 |
| CAS No | NA |
| Mol.F. | C19H19N7O4 |
| Mol.Wt. | 409.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014952 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014953 |
| CAS No | 2768787-11-5 |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 475.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014954 |
| CAS No | NA |
| Mol.F. | C25H27N7O2 |
| Mol.Wt. | 457.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014955 |
| CAS No | NA |
| Mol.F. | C11H17N3O2 |
| Mol.Wt. | 223.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014956 |
| CAS No | 2826147-23-1 |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014957 |
| CAS No | NA |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014958 |
| CAS No | NA |
| Mol.F. | C4H6N2O3 |
| Mol.Wt. | 130.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014959 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014960 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014961 |
| CAS No | 77817-40-4 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014962 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014963 |
| CAS No | NA |
| Mol.F. | C20H17F7N2O3 |
| Mol.Wt. | 466.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014964 |
| CAS No | NA |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.16 |
| INV STATUS | In Stock |
| CAT No | SRC-N014965 |
| CAS No | NA |
| Mol.F. | C20H22N2O2 |
| Mol.Wt. | 322.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014966 |
| CAS No | NA |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |